Kerry Group plc (LON:KYGA)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 9.35B -28.2% |
| Revenue (ttm) | 5.90B +7.7% |
| Net Income | 574.46M -0.5% |
| EPS | 3.48 +6.5% |
| Shares Out | n/a |
| PE Ratio | 16.27 |
| Forward PE | 13.38 |
| Dividend | 1.22 (1.83%) |
| Ex-Dividend Date | Apr 9, 2026 |
| Volume | 14,063 |
| Average Volume | 194,788 |
| Open | 67.40 |
| Previous Close | 66.80 |
| Day's Range | 67.40 - 68.40 |
| 52-Week Range | 64.35 - 100.50 |
| Beta | 0.55 |
| RSI | 49.25 |
| Earnings Date | Apr 28, 2026 |
About Kerry Group
Kerry Group plc, together with its subsidiaries, provides taste and nutrition solutions. The company offers taste solutions, such as dairy and dairy-free flavours, savoury flavours and extracts, smoke and grill, sweet flavours and extracts, and taste modulations. It also provides nutrition solutions, including enzymes, proteins, nutritional lipids and bases, soluble dietary fibre, wellness and health, and dairy ingredients. In addition, the company offers functional ingredients, food solutions, and beverage solutions. Further, it provides pharm... [Read more]
Financial Performance
In 2025, Kerry Group's revenue was 6.76 billion, a decrease of -2.48% compared to the previous year's 6.93 billion. Earnings were 658.50 million, a decrease of -10.33%.
Financial numbers in EUR Financial StatementsNews
Kerry shares fund strong local competition for Kingdom land
North Kerry is home to one of the most competitive land markets in the country. The land is good productive farming ground and, as the birthplace of Kerry Co-op, the area has a strong dairy tradition....
Kerry Group Transcript: Consumer Analyst Group of New York Conference (CAGNY) 2026
Focused on high single-digit earnings growth, the company leverages innovation, biotechnology, and digital transformation to outperform dynamic food and beverage markets. Strong financial performance, margin expansion, and disciplined capital allocation underpin continued growth and market leadership.
Kerry Group Earnings Call Transcript: Q4 2025
Delivered strong volume and margin growth in 2025, with robust innovation and strategic investments driving outperformance across regions. Outlook for 2026 includes continued margin expansion, high single-digit EPS growth, and further digital and operational efficiencies.
Kerry Group Earnings Call Transcript: Q3 2025
Delivered 3% volume growth and strong EBITDA margin expansion, outperforming end markets. Full-year guidance for adjusted EPS and volume growth reiterated, with robust innovation in food service and private label, and continued investment in biotechnology and digital transformation.
Kerry Group Earnings Call Transcript: Q2 2025
Strong H1 results with 3% volume growth and 100 bps EBITDA margin expansion, outpacing flat end markets. Full-year EPS guidance is maintained, with margin outlook raised and volume growth moderated to 3% amid continued innovation and robust cash generation.
Kerry Group Earnings Call Transcript: Q1 2025
Q1 2025 saw 3.1% volume growth and 6.3% revenue growth, with strong margin expansion and innovation-led gains in Americas and APMEA, while Europe remained flat. Full-year guidance for 7-11% EPS growth is maintained, with a new EUR 300 million share buyback announced.
Kerry Group Transcript: Consumer Analyst Group of New York Conference (CAGNY) 2025
The company has transformed into a focused taste and nutrition leader, leveraging innovation and sustainability to drive growth. Strong financial performance, robust partnerships, and targeted capital allocation underpin ambitious margin and EPS growth targets through 2028.
Kerry Group Earnings Call Transcript: Q4 2024
Delivered strong 2024 results with 3.3% volume growth, 120 bps EBITDA margin expansion, and robust cash generation. Outlook for 2025 targets continued outperformance, margin growth, and high single-digit EPS growth, supported by operational efficiencies and innovation.
Kerry Group Transcript: Investor Update
A €500 million sale of Kerry Dairy Ireland will transform the group into a pure-play B2B taste and nutrition company, boosting EBITDA margins, volume growth, and sustainability metrics, with minimal EPS dilution and improved cash flow conversion. Shareholder approval is required, and the transaction is set to close by January 2025.
Kerry Group Earnings Call Transcript: Q3 2024
Q3 saw strong volume growth and margin expansion, led by Foodservice and robust Americas performance. Full-year guidance for 7%-10% adjusted EPS growth is maintained, with continued focus on innovation, capital flexibility, and market penetration opportunities.
Kerry Group Transcript: Investor Day 2024
Kerry targets mid single-digit volume growth, margin expansion to 20%+ by 2026, and a $15B renovation opportunity, supported by investments in biotechnology and digital innovation. A €300M share buyback and strong sustainability progress were also announced.
Kerry Group Earnings Call Transcript: Q2 2024
Strong H1 2024 results with 3.1% T&N volume growth, 6.6% EBITDA increase, and upgraded EPS guidance to 7%-10% growth. Margin expansion, robust cash flow, and strategic investments, including acquisitions and share buybacks, support continued outperformance in key markets.